Amniotic Membrane Market by Type and Geography - Forecast and Analysis 2022-2026

The amniotic membrane market share is expected to increase by USD 1.86 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 13.5%.

This amniotic membrane market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers amniotic membrane market segmentations by type (cryopreserved amniotic membrane and dehydrated amniotic membrane) and geography (North America, Europe, Asia, and Rest of World (ROW)). The amniotic membrane market report also offers information on several market vendors, including Amnio Technology LLC, Applied Biologics LLC, BIOHEALING, Celularity Inc., Flower Orthopedics Corp, Human Regenerative Technologies LLC, Integra Lifesciences Holdings Corp., Katena Products Inc., MiMedx Group Inc., Next Biosciences, NuVision Biotherapies Ltd, Organogenesis Inc., Orthofix Medical Inc., Reea carewell products, Skye Biologics Holdings LLC, Stryker Corp., Surgenex LLC, SURGITECH INNOVATION, and TissueTech Inc among others.

What will the Amniotic Membrane Market Size be During the Forecast Period?

Download Report Sample to Unlock the Amniotic Membrane Market Size for the Forecast Period and Other Important Statistics

Amniotic Membrane Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The extensive use of amniotic membrane transplantation in ophthalmic surgeries is notably driving the amniotic membrane market growth, although factors such as limited supply of amniotic membranes may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the amniotic membrane industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Amniotic Membrane Market Driver

The extensive use of amniotic membrane transplantation in ophthalmic surgeries is a major factor driving the global amniotic membrane market share growth during the forecast period. Amniotic membrane transplantations have transformed the treatment of ophthalmic conditions, specifically treatments related to ocular surface reconstruction. Ocular surface reconstruction procedures have significantly improved due to the characteristic properties of amniotic membranes that facilitate the migration of epithelial cells, reinforce cellular adhesion, and encourage epithelial diffraction. Additionally, amniotic membranes can modulate stromal scarring and have anti-inflammatory properties. As a result, ophthalmologists are increasingly using amniotic membrane-based transplantation in corneal surface reconstruction for the treatment of bullous keratopathy, glaucoma or cataract, partial limbal stem cell deficiency, persistent epithelial defects, and corneoscleral ulcers. Moreover, the increasing number of ophthalmic surgeries is promoting the demand for amniotic membranes among end-users such as hospitals and clinics. Similarly, eye infections such as keratitis, which results in vision loss, are becoming common among people that use contact lenses improperly. Such eye infections and disorders increase the demand for ophthalmic reconstruction surgeries across the globe, thereby driving the growth of amniotic membrane products.

Key Amniotic Membrane Market Trend

The growing reimbursement coverage for new products is another factor supporting the global amniotic membrane market share growth during the forecast period. To provide value-based care, governments across the globe are increasingly undergoing changes in their reimbursement structure to cover newly introduced healthcare products. Tissue-engineered products such as amniotic membranes are considered highly expensive owing to the involvement of a considerable amount of direct and indirect costs in sourcing, storage, transfer, and application. The involvement of such high costs has been challenging the market vendors. However, government organizations and market vendors are focusing on reimbursing such costs and providing value-based care. This has led to the revision of reimbursement policies related to amniotic membrane products. Market vendors are focusing on collaborating with third-party payers and Medicare administrative contractors to enhance the reimbursement coverage of their amniotic membrane-based products to increase their adoption. Additionally, in order to boost awareness of reimbursement coverage for different products, vendors are disclosing information and guidelines on their websites. Such activities are reducing the cost of amniotic membranes and increasing awareness regarding coverage policies among patients and medical practitioners which is expected to drive market growth during the forecast years.

Key Amniotic Membrane Market Challenge

The limited supply of amniotic membranes will be a major challenge for the global amniotic membranes market share growth during the forecast period. The demand for amniotic membranes has risen owing to their increasing adoption. However, market vendors are facing major issues in meeting such high demands as amniotic membranes can only be sourced during birth, resulting in their limited availability and supply. Moreover, the limitation in supply results in an increase in the price of amniotic membranes, thereby raising the overall healthcare cost. Additionally, amniotic membranes can only be retrieved from donors that have previously been screened serologically for the detection of any potential communicable disease. This further limit the availability of sources and creates a considerable gap in demand and supply, which results in higher dependency of market vendors on cryopreservation facilities and further aids the storage cost. Furthermore, to overcome concerns related to the limited supply, end-users focus on adopting viable alternatives such as polymeric scaffolds that can be synthetically manufactured. All these obstacles hamper the growth of the global amniotic membrane market.

This amniotic membrane market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global amniotic membranes market as part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the amniotic membrane market during the forecast period.

Who are the Major Amniotic Membrane Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

• Amnio Technology LLC
• Applied Biologics LLC
• BIOHEALING
• Celularity Inc.
• Flower Orthopedics Corp
• Human Regenerative Technologies LLC
• Integra Lifesciences Holdings Corp.
• Katena Products Inc.
• MiMedx Group Inc.
• Next Biosciences
• NuVision Biotherapies Ltd
• Organogenesis Inc.
• Orthofix Medical Inc.
• Reea carewell products
• Skye Biologics Holdings LLC
• Stryker Corp.
• Surgenex LLC
• SURGITECH INNOVATION
• TissueTech Inc

This statistical study of the amniotic membrane market encompasses successful business strategies deployed by the key vendors. The amniotic membrane market is fragmented and the vendors are deploying growth strategies such as acquiring small vendors that have promising patented technologies and product offerings to compete in the market.

Product Insights and News

• Celularity Inc.- The company offers amniotic membranes by the brand name BIOVANCE.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The amniotic membrane market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Amniotic Membrane Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the amniotic membrane market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Amniotic Membrane Market?

For more insights on the market share of various regions Request PDF Sample now!

56% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for amniotic membrane market in North America. Market growth in this region will be slower than the growth of the market in Asian regions.

The growing adoption of advanced wound care treatments due to substantial awareness of improved healthcare options among people will facilitate the amniotic membrane market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

After the outbreak of COVID-19, the demand for amniotic membranes has declined significantly in the region, owing to the postponement of most elective surgeries. Owing to the significant prevalence of COVID-19 across the US and other countries in the region, the CDC is urging all ophthalmologists to cease providing any treatment other than urgent or emergency care. Several guidelines have been issued for clinics and hospitals that offer elective ophthalmic care. Furthermore, the economic recession and disrupted supply chains have also affected operations in ophthalmic clinics and hospitals. Owing to these factors, the market for amniotic membranes declined in 2020.

What are the Revenue-generating Type Segments in the Amniotic Membrane Market?

To gain further insights on the market contribution of various segments Request PDF Sample

The amniotic membrane market share growth by the cryopreserved amniotic membrane will be significant during the forecast period. Cryopreserved membranes are finding wide applications such as in anti-inflammatory therapies and regenerative procedures that are largely enhanced due to the substantial availability of biologic components. These membranes are significant as they retain the integrity of the amniotic membrane and the native architecture of the extracellular matrix (ECM) during long-duration storage requirements. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the amniotic membrane market size and actionable market insights on post COVID-19 impact on each segment.

Request PDF sample

What are the Key Data Covered in this Amniotic Membrane Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive amniotic membrane market growth during the next five years
• Precise estimation of the amniotic membrane market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the amniotic membrane industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of amniotic membrane market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch